MacroGenics PE Ratio 2012-2023 | MGNX
Current and historical p/e ratio for MacroGenics (MGNX) from 2012 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MacroGenics PE ratio as of April 17, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
MacroGenics PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-18 | 16.07 | 0.00 | |
2023-12-31 | 9.62 | $-0.16 | 0.00 |
2023-09-30 | 4.66 | $0.80 | 5.83 |
2023-06-30 | 5.35 | $0.12 | 44.58 |
2023-03-31 | 7.17 | $-1.47 | 0.00 |
2022-12-31 | 6.71 | $-1.94 | 0.00 |
2022-09-30 | 3.46 | $-3.10 | 0.00 |
2022-06-30 | 2.95 | $-3.56 | 0.00 |
2022-03-31 | 8.81 | $-3.55 | 0.00 |
2021-12-31 | 16.05 | $-3.37 | 0.00 |
2021-09-30 | 20.94 | $-2.40 | 0.00 |
2021-06-30 | 26.86 | $-2.20 | 0.00 |
2021-03-31 | 31.85 | $-2.48 | 0.00 |
2020-12-31 | 22.86 | $-2.49 | 0.00 |
2020-09-30 | 25.19 | $-3.13 | 0.00 |
2020-06-30 | 27.92 | $-3.38 | 0.00 |
2020-03-31 | 5.82 | $-3.09 | 0.00 |
2019-12-31 | 10.88 | $-3.17 | 0.00 |
2019-09-30 | 12.76 | $-3.61 | 0.00 |
2019-06-30 | 16.97 | $-3.51 | 0.00 |
2019-03-31 | 17.98 | $-3.89 | 0.00 |
2018-12-31 | 12.70 | $-4.24 | 0.00 |
2018-09-30 | 21.44 | $-0.38 | 0.00 |
2018-06-30 | 20.65 | $-0.85 | 0.00 |
2018-03-31 | 25.16 | $-0.96 | 0.00 |
2017-12-31 | 19.00 | $-0.70 | 0.00 |
2017-09-30 | 18.48 | $-4.50 | 0.00 |
2017-06-30 | 17.51 | $-4.19 | 0.00 |
2017-03-31 | 18.60 | $-1.93 | 0.00 |
2016-12-31 | 20.44 | $-1.73 | 0.00 |
2016-09-30 | 29.91 | $-1.62 | 0.00 |
2016-06-30 | 26.99 | $-1.11 | 0.00 |
2016-03-31 | 18.75 | $-2.94 | 0.00 |
2015-12-31 | 30.97 | $-0.64 | 0.00 |
2015-09-30 | 21.42 | $-0.44 | 0.00 |
2015-06-30 | 37.97 | $-0.12 | 0.00 |
2015-03-31 | 31.37 | $0.15 | 209.13 |
2014-12-31 | 35.07 | $-1.39 | 0.00 |
2014-09-30 | 20.90 | $-0.84 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.007B | $0.059B |
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
Stryker (SYK) | United States | $127.849B | 31.70 |
Medtronic (MDT) | Ireland | $105.004B | 14.86 |
Boston Scientific (BSX) | United States | $99.704B | 33.15 |
EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
ResMed (RMD) | United States | $25.568B | 25.56 |
Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
Terumo (TRUMY) | Japan | $24.880B | 35.14 |
Baxter (BAX) | United States | $20.069B | 14.64 |
Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
Insulet (PODD) | United States | $11.642B | 61.12 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
Demant (WILYY) | Denmark | $10.001B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
Haemonetics (HAE) | United States | $4.311B | 22.05 |
Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
Envista Holdings (NVST) | United States | $3.367B | 12.80 |
Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
ICU Medical (ICUI) | United States | $2.336B | 17.43 |
TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
Owens & Minor (OMI) | United States | $1.836B | 17.62 |
Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
InMode (INMD) | Israel | $1.465B | 7.59 |
LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
Warby Parker (WRBY) | United States | $1.189B | 0.00 |
AtriCure (ATRC) | United States | $1.134B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
Evolus (EOLS) | United States | $0.674B | 0.00 |
Jin Medical (ZJYL) | China | $0.631B | 0.00 |
Quanterix (QTRX) | United States | $0.602B | 0.00 |
Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
Valneva SE (VALN) | France | $0.538B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
PetIQ (PETQ) | United States | $0.469B | 17.50 |
ZimVie (ZIMV) | United States | $0.417B | 25.55 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
Zynex (ZYXI) | United States | $0.388B | 44.70 |
Surmodics (SRDX) | United States | $0.378B | 40.80 |
Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
Cerus (CERS) | United States | $0.297B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
Omeros (OMER) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
Veru (VERU) | United States | $0.170B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
InterCure (INCR) | Israel | $0.108B | 18.15 |
Fonar (FONR) | United States | $0.105B | 8.98 |
Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Safety Shot (SHOT) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.084B | 0.00 |
Chimerix (CMRX) | United States | $0.081B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 14.04 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
ProSomnus (OSA) | United States | $0.008B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |